HEADER TRANSCRIPTION REGULATOR, OXIDOREDUCTASE 23-MAY-08 3D8C TITLE FACTOR INHIBITING HIF-1 ALPHA D201G MUTANT IN COMPLEX WITH ZN(II), TITLE 2 ALPHA-KETOGLUTARATE AND HIF-1 ALPHA 19MER COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXIA-INDUCIBLE FACTOR 1 ALPHA INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HYPOXIA-INDUCIBLE FACTOR ASPARAGINE HYDROXYLASE, FACTOR COMPND 5 INHIBITING HIF-1, FIH-1; COMPND 6 EC: 1.14.11.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: HYPOXIA-INDUCIBLE FACTOR 1 ALPHA; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: CTAD; COMPND 13 SYNONYM: HIF-1 ALPHA, HIF1 ALPHA, ARNT- INTERACTING PROTEIN, MEMBER COMPND 14 OF PAS PROTEIN 1, MOP1; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HIF1AN, FIH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A(+); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: SYNTHETIC PEPTIDE FRAGMENT OF HIF-1 ALPHA KEYWDS FIH, HIF, DSBH, OXYGENASE, TRANSCRIPTION, HYPOXIA, INHIBITOR 2- KEYWDS 2 OXOGLUTARATE, ASPARAGINYL HYDROXYLASE, TRANSCRIPTION REGULATOR, KEYWDS 3 OXIDOREDUCTASE, DIOXYGENASE, IRON, METAL-BINDING, NUCLEUS, KEYWDS 4 TRANSCRIPTION REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR M.A.MCDONOUGH,R.CHOWDHURY,C.J.SCHOFIELD REVDAT 6 30-AUG-23 3D8C 1 REMARK REVDAT 5 20-OCT-21 3D8C 1 REMARK SEQADV LINK REVDAT 4 13-JUL-11 3D8C 1 VERSN REVDAT 3 12-MAY-09 3D8C 1 JRNL REVDAT 2 24-FEB-09 3D8C 1 VERSN REVDAT 1 12-AUG-08 3D8C 0 JRNL AUTH K.S.HEWITSON,S.L.HOLMES,D.EHRISMANN,A.P.HARDY,R.CHOWDHURY, JRNL AUTH 2 C.J.SCHOFIELD,M.A.MCDONOUGH JRNL TITL EVIDENCE THAT TWO ENZYME-DERIVED HISTIDINE LIGANDS ARE JRNL TITL 2 SUFFICIENT FOR IRON BINDING AND CATALYSIS BY FACTOR JRNL TITL 3 INHIBITING HIF (FIH). JRNL REF J.BIOL.CHEM. V. 283 25971 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18611856 JRNL DOI 10.1074/JBC.M804999200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.M.ELKINS,K.S.HEWITSON,L.A.MCNEILL,J.F.SEIBEL, REMARK 1 AUTH 2 I.SCHLEMMINGER,C.W.PUGH,P.J.RATCLIFFE,C.J.SCHOFIELD REMARK 1 TITL STRUCTURE OF FACTOR-INHIBITING HYPOXIA-INDUCIBLE FACTOR REMARK 1 TITL 2 (HIF) REVEALS MECHANISM OF OXIDATIVE MODIFICATION OF HIF-1 REMARK 1 TITL 3 ALPHA REMARK 1 REF J.BIOL.CHEM. V. 278 1802 2003 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.A.MCDONOUGH,L.A.MCNEILL,M.TILLIET,C.A.PAPAMICAEL,Q.Y.CHEN, REMARK 1 AUTH 2 B.BANERJI,K.S.HEWITSON,C.J.SCHOFIELD REMARK 1 TITL SELECTIVE INHIBITION OF FACTOR INHIBITING HYPOXIA INDUCIBLE REMARK 1 TITL 2 FACTOR REMARK 1 REF J.AM.CHEM.SOC. V. 127 7680 2005 REMARK 1 REFN ISSN 0002-7863 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 139071.030 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 31888 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3216 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4331 REMARK 3 BIN R VALUE (WORKING SET) : 0.2900 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 511 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2822 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 223 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.12000 REMARK 3 B22 (A**2) : -6.12000 REMARK 3 B33 (A**2) : 12.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.25 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.890 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 82.08 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : GOL.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 2OG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : GOL.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : 2OG.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3D8C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047719. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9696 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33850 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 13.90 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : 0.04340 REMARK 200 FOR THE DATA SET : 23.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 0.74300 REMARK 200 R SYM FOR SHELL (I) : 0.25690 REMARK 200 FOR SHELL : 3.660 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: ISOMORPHOUS WITH 1H2N REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: 1H2N REMARK 200 REMARK 200 REMARK: REJECTION CRITERIA AS REJECTION PROBABILITY, REJECTION REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M AMMONIUM SULPHATE, 6% PEG400, REMARK 280 0.1M HEPES PH7.5, 24MG/ML PROTEIN WITH 1MM FE(II)SO4, 1MM ALPHA- REMARK 280 KETOGLUTARATE, 1MM HIF-1ALPHA PEPTIDE, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298.0K, PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 74.03250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.21350 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.21350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 37.01625 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.21350 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.21350 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 111.04875 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.21350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.21350 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 37.01625 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.21350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.21350 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 111.04875 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 74.03250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6890 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 86.42700 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 86.42700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 74.03250 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 THR A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 GLU A 7 REMARK 465 ALA A 8 REMARK 465 ASP B 788 REMARK 465 GLU B 789 REMARK 465 SER B 790 REMARK 465 GLY B 791 REMARK 465 LEU B 792 REMARK 465 PRO B 793 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 19 OE1 OE2 REMARK 470 GLU A 29 CD OE1 OE2 REMARK 470 ARG A 40 CD NE CZ NH1 NH2 REMARK 470 ASN A 87 CB CG OD1 ND2 REMARK 470 LYS A 106 NZ REMARK 470 GLN A 112 CD OE1 NE2 REMARK 470 LYS A 115 CG CD CE NZ REMARK 470 LYS A 131 CD CE NZ REMARK 470 ASP A 134 CG OD1 OD2 REMARK 470 ILE A 135 CB CG1 CG2 CD1 REMARK 470 GLN A 136 CB CG CD OE1 NE2 REMARK 470 GLN A 137 CG CD OE1 NE2 REMARK 470 ASP A 152 CG OD1 OD2 REMARK 470 LYS A 157 CE NZ REMARK 470 LYS A 172 CD CE NZ REMARK 470 GLU A 250 CD OE1 OE2 REMARK 470 ARG A 305 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 306 CG1 CG2 CD1 REMARK 470 GLU A 307 CG CD OE1 OE2 REMARK 470 LYS A 311 CD CE NZ REMARK 470 GLN B 794 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 238 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 100 72.40 -105.19 REMARK 500 ASN A 151 -167.94 -111.03 REMARK 500 ARG A 238 -9.58 78.55 REMARK 500 ASN A 246 75.60 -156.26 REMARK 500 TYR A 276 -13.37 81.17 REMARK 500 PRO A 303 159.38 -46.70 REMARK 500 ASN A 332 117.08 -165.83 REMARK 500 ASP B 799 -151.69 -98.50 REMARK 500 CYS B 800 41.00 -145.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 350 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 199 NE2 REMARK 620 2 HIS A 279 NE2 93.3 REMARK 620 3 HOH A1001 O 98.0 102.5 REMARK 620 4 AKG A1351 O2 160.5 100.9 92.0 REMARK 620 5 AKG A1351 O5 84.7 115.0 142.2 77.2 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AKG A 1351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ILM RELATED DB: PDB REMARK 900 FACTOR INHIBITING HIF-1 ALPHA D201A MUTANT IN COMPLEX WITH 2 FE(II), REMARK 900 ALPHA-KETOGLUTARATE AND HIF-1 ALPHA 35MER REMARK 900 RELATED ID: 1H2K RELATED DB: PDB REMARK 900 RELATED ID: 1H2L RELATED DB: PDB REMARK 900 RELATED ID: 1H2M RELATED DB: PDB REMARK 900 RELATED ID: 1H2N RELATED DB: PDB REMARK 900 RELATED ID: 1YCI RELATED DB: PDB DBREF 3D8C A 11 349 UNP Q9NWT6 HIF1N_HUMAN 11 349 DBREF 3D8C B 788 806 PDB 3D8C 3D8C 788 806 SEQADV 3D8C MET A 1 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 2 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 3 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C THR A 4 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 5 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 6 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C GLU A 7 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 8 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C VAL A 9 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C ALA A 10 UNP Q9NWT6 EXPRESSION TAG SEQADV 3D8C GLY A 201 UNP Q9NWT6 ASP 201 ENGINEERED MUTATION SEQRES 1 A 349 MET ALA ALA THR ALA ALA GLU ALA VAL ALA SER GLY SER SEQRES 2 A 349 GLY GLU PRO ARG GLU GLU ALA GLY ALA LEU GLY PRO ALA SEQRES 3 A 349 TRP ASP GLU SER GLN LEU ARG SER TYR SER PHE PRO THR SEQRES 4 A 349 ARG PRO ILE PRO ARG LEU SER GLN SER ASP PRO ARG ALA SEQRES 5 A 349 GLU GLU LEU ILE GLU ASN GLU GLU PRO VAL VAL LEU THR SEQRES 6 A 349 ASP THR ASN LEU VAL TYR PRO ALA LEU LYS TRP ASP LEU SEQRES 7 A 349 GLU TYR LEU GLN GLU ASN ILE GLY ASN GLY ASP PHE SER SEQRES 8 A 349 VAL TYR SER ALA SER THR HIS LYS PHE LEU TYR TYR ASP SEQRES 9 A 349 GLU LYS LYS MET ALA ASN PHE GLN ASN PHE LYS PRO ARG SEQRES 10 A 349 SER ASN ARG GLU GLU MET LYS PHE HIS GLU PHE VAL GLU SEQRES 11 A 349 LYS LEU GLN ASP ILE GLN GLN ARG GLY GLY GLU GLU ARG SEQRES 12 A 349 LEU TYR LEU GLN GLN THR LEU ASN ASP THR VAL GLY ARG SEQRES 13 A 349 LYS ILE VAL MET ASP PHE LEU GLY PHE ASN TRP ASN TRP SEQRES 14 A 349 ILE ASN LYS GLN GLN GLY LYS ARG GLY TRP GLY GLN LEU SEQRES 15 A 349 THR SER ASN LEU LEU LEU ILE GLY MET GLU GLY ASN VAL SEQRES 16 A 349 THR PRO ALA HIS TYR GLY GLU GLN GLN ASN PHE PHE ALA SEQRES 17 A 349 GLN ILE LYS GLY TYR LYS ARG CYS ILE LEU PHE PRO PRO SEQRES 18 A 349 ASP GLN PHE GLU CYS LEU TYR PRO TYR PRO VAL HIS HIS SEQRES 19 A 349 PRO CYS ASP ARG GLN SER GLN VAL ASP PHE ASP ASN PRO SEQRES 20 A 349 ASP TYR GLU ARG PHE PRO ASN PHE GLN ASN VAL VAL GLY SEQRES 21 A 349 TYR GLU THR VAL VAL GLY PRO GLY ASP VAL LEU TYR ILE SEQRES 22 A 349 PRO MET TYR TRP TRP HIS HIS ILE GLU SER LEU LEU ASN SEQRES 23 A 349 GLY GLY ILE THR ILE THR VAL ASN PHE TRP TYR LYS GLY SEQRES 24 A 349 ALA PRO THR PRO LYS ARG ILE GLU TYR PRO LEU LYS ALA SEQRES 25 A 349 HIS GLN LYS VAL ALA ILE MET ARG ASN ILE GLU LYS MET SEQRES 26 A 349 LEU GLY GLU ALA LEU GLY ASN PRO GLN GLU VAL GLY PRO SEQRES 27 A 349 LEU LEU ASN THR MET ILE LYS GLY ARG TYR ASN SEQRES 1 B 19 ASP GLU SER GLY LEU PRO GLN LEU THR SER TYR ASP CYS SEQRES 2 B 19 GLU VAL ASN ALA PRO ILE HET ZN A 350 1 HET SO4 A 501 5 HET SO4 A 502 5 HET AKG A1351 10 HET GOL A2000 6 HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETNAM AKG 2-OXOGLUTARIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN ZN 2+ FORMUL 4 SO4 2(O4 S 2-) FORMUL 6 AKG C5 H6 O5 FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *223(H2 O) HELIX 1 1 ASP A 28 LEU A 32 5 5 HELIX 2 2 ASP A 49 ASN A 58 1 10 HELIX 3 3 VAL A 70 TRP A 76 5 7 HELIX 4 4 ASP A 77 ILE A 85 1 9 HELIX 5 5 ASP A 104 MET A 108 5 5 HELIX 6 6 LYS A 124 GLY A 139 1 16 HELIX 7 7 GLY A 155 GLY A 164 1 10 HELIX 8 8 ASN A 166 ARG A 177 1 12 HELIX 9 9 PRO A 220 ASP A 222 5 3 HELIX 10 10 GLN A 223 TYR A 228 1 6 HELIX 11 11 PHE A 252 VAL A 258 5 7 HELIX 12 12 LYS A 311 LEU A 330 1 20 HELIX 13 13 ASN A 332 GLN A 334 5 3 HELIX 14 14 GLU A 335 LYS A 345 1 11 SHEET 1 A 5 THR A 39 PRO A 41 0 SHEET 2 A 5 GLY A 260 VAL A 265 1 O GLY A 260 N ARG A 40 SHEET 3 A 5 LYS A 214 PHE A 219 -1 N LEU A 218 O TYR A 261 SHEET 4 A 5 TRP A 278 SER A 283 -1 O HIS A 280 N ILE A 217 SHEET 5 A 5 VAL A 195 HIS A 199 -1 N THR A 196 O ILE A 281 SHEET 1 B 9 ARG A 44 LEU A 45 0 SHEET 2 B 9 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 B 9 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 B 9 GLN A 203 LYS A 211 -1 N PHE A 207 O LEU A 271 SHEET 5 B 9 THR A 290 LYS A 298 -1 O TYR A 297 N GLN A 204 SHEET 6 B 9 LEU A 186 GLY A 190 -1 N LEU A 188 O THR A 292 SHEET 7 B 9 ARG A 143 THR A 149 -1 N GLN A 148 O LEU A 187 SHEET 8 B 9 PHE A 90 ALA A 95 -1 N ALA A 95 O ARG A 143 SHEET 9 B 9 SER A 118 MET A 123 -1 O MET A 123 N PHE A 90 SHEET 1 C 6 ARG A 44 LEU A 45 0 SHEET 2 C 6 VAL A 62 LEU A 64 1 O VAL A 63 N LEU A 45 SHEET 3 C 6 VAL A 270 ILE A 273 -1 O VAL A 270 N LEU A 64 SHEET 4 C 6 GLN A 203 LYS A 211 -1 N PHE A 207 O LEU A 271 SHEET 5 C 6 THR A 290 LYS A 298 -1 O TYR A 297 N GLN A 204 SHEET 6 C 6 LEU A 182 SER A 184 -1 N THR A 183 O TRP A 296 LINK NE2 HIS A 199 ZN ZN A 350 1555 1555 2.11 LINK NE2 HIS A 279 ZN ZN A 350 1555 1555 2.26 LINK ZN ZN A 350 O HOH A1001 1555 1555 2.37 LINK ZN ZN A 350 O2 AKG A1351 1555 1555 2.17 LINK ZN ZN A 350 O5 AKG A1351 1555 1555 2.20 CISPEP 1 TYR A 308 PRO A 309 0 0.08 SITE 1 AC1 3 HIS A 199 HIS A 279 HOH A1001 SITE 1 AC2 5 ARG A 138 GLY A 140 GLU A 141 GLU A 142 SITE 2 AC2 5 HOH A1139 SITE 1 AC3 5 ARG A 143 GLU A 192 GLY A 193 LEU A 285 SITE 2 AC3 5 ASN A 286 SITE 1 AC4 10 TYR A 145 THR A 196 HIS A 199 ASN A 205 SITE 2 AC4 10 PHE A 207 LYS A 214 HIS A 279 ILE A 281 SITE 3 AC4 10 ASN A 294 TRP A 296 SITE 1 AC5 6 LYS A 99 TYR A 230 SER A 240 GLN A 241 SITE 2 AC5 6 ASP A 243 HOH A1078 CRYST1 86.427 86.427 148.065 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011570 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011570 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006754 0.00000